RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 23-33
  • American Ebola patients treated with ZMapp experimental drug

    American Ebola patients treated with ZMapp experimental drug
    An American doctor who contracted Ebola treating victims of the deadly virus in Liberia has recovered and has been discharged Thursday by the Atlanta hospital that treated him with an experimental drug. Dr. Kent Brantly of Texas was given ZMapp, a drug...
  • Pfizer back for AstraZeneca? Year-end move seen most likely

    LONDON (Reuters) - Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, fueled by speculation of renewed takeover interest from Pfizer, following an abortive $118 billion (71 billion pounds) takeover attempt in May. But while...
  • Experimental Ebola drugs needed for 'up to 30,000 people'

    LONDON (Reuters) - Up to 30,000 people could have used experimental treatments or vaccines so far in the world's worst outbreak of Ebola currently plaguing West Africa, British scientists said on Wednesday. The calculation highlights the dilemma facing...
  • Amicus's lead drug nears approval as late-stage trial succeeds

    (Reuters) - Amicus Therapeutics Inc moved a step closer to bringing its first drug to the market after trial results paved the way for its lead drug to become the first oral treatment for patients with a disorder that causes an abnormal build-up of fat....
  • Sanford-Burnham taps new CEO from pharma industry

    Sanford-Burnham taps new CEO from pharma industry
    With the selection of Perry Nisen as its new chief executive officer today, Sanford-Burnham Medical Research Institute is signaling a commitment to its new long-term strategic vision of open collaboration for the development of breakthrough clinical...
  • U.S. speeds up human clinical trials for promising Ebola vaccine

    U.S. speeds up human clinical trials for promising Ebola vaccine
    Researchers at the National Institutes of Health are accelerating human clinical trials for what scientists hope is a promising new vaccine to combat the deadly Ebola virus. Phase 1 of the clinical trials, which were previously not expected to begin...
  • P&G eyes Duracell, Braun in sweeping brand culling: sources

    NEW YORK (Reuters) - Procter & Gamble Co is working with advisors including Goldman Sachs Group as the world's largest household products maker reviews up to 100 underperforming brands for potential divestiture, people familiar with the matter said....
  • Extreme medicine: The search for new antibiotics

    NORWICH England (Reuters) - Pampering leafcutter ants with fragrant rose petals and fresh oranges may seem an unlikely way to rescue modern medicine, but scientists at a lab in eastern England think it's well worth trying.     As the world cries out...
  • An O.C. couple do the math: Same drug is far cheaper in Canada

    An O.C. couple do the math: Same drug is far cheaper in Canada
    Bent and Henni Christensen consider themselves patriotic Americans and strong supporters of Medicare. Nevertheless, the Huntington Beach couple buy most of their prescription drugs from an online Canadian pharmacy at prices much lower than in the United...
  • Another reminder of why corporations cannot police themselves

    What kind of people would knowingly expose someone to the risk of infection just to make a buck? Read carefully the allegations underlying the recent $97 million settlement between the U.S. Department of Justice and Community Health Systems and that...
  • Close loopholes that let U.S. firms avoid taxes by using inversions

    Close loopholes that let U.S. firms avoid taxes by using inversions
    It's both endearing and infuriating to watch American corporate executives wring their hands about how the injustices of the U.S. tax code are forcing them — forcing them! — to reincorporate overseas through the procedure known as inversion....